With WHO prequalification, global health organizations can consider the Aptima HIV-1 Quant Dx for public-sector procurement in resource-limited countries.

The study is the first to demonstrate the design features and operational characteristics of Cepheid's Xpert MTB/RIF Ultra assay.

Using the grant funding, the investigators are aiming to advance the precision diagnosis and treatment of lung cancer.

With genotyping data from tens of thousands of individuals with or without lung cancer, researchers identified eight known and 10 new loci associated with lung cancer.

The kit is a qualitative nucleic acid assay designed to test for Zika, dengue, and chikungunya viruses simultaneously.

Researchers have sequenced and analyzed a genome assembly for a Zika virus reference strain from French Polynesia that might be used as part of diagnostic assays.

The RealStar Zika Virus RT-PCR Kit 1.0 has been listed by the World Health Organization as eligible for procurement agencies and member states.

The GenomeWeb Index fell half a percent in June, underperforming the Dow Jones Industrial Average, but far outpacing the Nasdaq and Nasdaq Biotech Index.

Prequalification now enables procurement in numerous countries within sub-Saharan Africa that have regulations requiring this type of oversight.

WHO Search Begins

The World Health Organization has begun looking for a new director general, Stat News says.


Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.